Get startedLog in
    Picture of Percheron Therapeutics logo

    PER — Percheron Therapeutics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Antisense Therapeutics Says Atl1102 Phase IIB DMD Trial Bulgarian Approval Received

    Picture of Percheron Therapeutics logoPercheron Therapeutics
    26/04/2023 02:39
    April 26 (Reuters) - Antisense Therapeutics Ltd
 ANP.AX :
    * ATL1102 PHASE IIB DMD TRIAL BULGARIAN APPROVAL RECEIVED

Source text for Eikon:  ID:nASX4lPckq 
Further company coverage:  ANP.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Percheron Therapeutics

    See all news